Mammography News and Research

RSS

A mammogram is a safe test used to look for any problems with a woman's breasts. The test uses a special, low-dose x-ray machine to take pictures of both breasts. The results are recorded on x-ray film or directly onto a computer for a radiologist to examine.

Mammograms allow the doctor to have a closer look for breast lumps and changes in breast tissue. They can show small lumps or growths that a doctor or woman may not be able to feel when doing a clinical breast exam. "Mammography" is the best screening tool that doctors have for finding breast cancer.

If a lump is found, your doctor may order other tests, such as ultrasound or a biopsy--a test where a small amount of tissue is taken from the lump and area around the lump. The tissue is sent to a lab to look for cancer or changes that may mean cancer is likely to develop. Breast lumps or growths can be benign (not cancer) or malignant (cancer). Finding breast cancer early means that a woman has a better chance of surviving the disease. There are also more choices for treatment when breast cancer is found early.

Aspirin does not improve survival among breast cancer patients with aggressive disease

Whether aspirin may help prevent or reduce the risk of breast cancer remains a hotly debated research question. While past studies have indicated a potential benefit, most recently in hormone receptor-positive breast cancers, one new study from Penn Medicine suggests otherwise.

9 Dec 2015

Hybrid Photon Counting (HPC) technology based on newest ASIC platform for X-ray imaging

DECTRIS Ltd. has announced its Hybrid Photon Counting (HPC) technology based on the newest IBEX ASIC platform for X-ray medical imaging equipment.

7 Dec 2015

False-positive mammograms may indicate future breast cancer risk

Women who receive a false-positive mammogram result may be at greater risk of developing breast cancer for up to ten years afterwards, report researchers from the US.

3 Dec 2015

Philips unveils complete range of data driven radiology solutions at RSNA 2015

Royal Philips revealed a portfolio of data driven radiology solutions at the 2015 Radiological Society of North America Annual Meeting, beginning today through December 4 at McCormick Place in Chicago.

1 Dec 2015

Philips launches IntelliSpace Portal 8.0 platform for diagnosis and treatment of cancer

Strengthening its leadership in connected healthcare informatics, Royal Philips (NYSE: PHG, AEX: PHIA) today announced IntelliSpace Portal 8.0 , the latest edition of its advanced data sharing, analytics and visualization platform that helps radiologists detect, diagnose and follow-up on treatment of diseases.

1 Dec 2015

Sectra provides Breast Imaging PACS to Kentucky Breast Care

International medical imaging IT company Sectra announces that Kentucky Breast Care has entered into a multi-year agreement to provide Breast Imaging PACS for their women's healthcare practice. This will allow Kentucky Breast Care to increase collaboration with sub-specialists around the US and offer exceptional care for their patients.

30 Nov 2015

Study: Medicaid expansion increases use of breast cancer screening among low-income women

Low-income women in Medicaid expansion states in the U.S. are more likely to have a breast screening performed than those in non-expansion states, according to a study presented today at the annual meeting of the Radiological Society of North America.

30 Nov 2015

Breast Center of Acadiana to deploy Sectra Breast Imaging PACS in two freestanding imaging centers

International medical imaging IT company Sectra announces that Breast Center of Acadiana has entered into a multi-year agreement to deploy Breast Imaging PACS in its two freestanding imaging centers. This investment will provide the Breast Center a future-proof platform capable of expanding with the practice.

24 Nov 2015

Teledyne DALSA's CMOS X-Ray detector for mammography to be introduced at RSNA 2015 Technical Exhibition

Teledyne DALSA, a Teledyne Technologies company and global leader in digital X-Ray image sensing technology, will introduce its CMOS X-Ray detector for mammography at the RSNA 2015 Technical Exhibition, November 29 to December 3, at McCormick Place in Chicago.

24 Nov 2015

Houston Methodist investigator awarded NCI grant to study detection strategies for breast cancer-specific subtypes

The National Cancer Institute awarded Houston Methodist investigator Randa El-Zein, M.B., Ch.B., Ph.D., a $2.8 million, five-year U01 grant to combine mammography features with blood-based biomarkers to more precisely predict a woman's risk for breast cancer-specific subtypes.

13 Nov 2015

Adjunctive ultrasonography improves breast cancer detection

The addition of ultrasonography to mammography significantly improves the rate of detection of breast cancers in Japanese women, according to trial findings published in The Lancet.

10 Nov 2015

Combination of ultrasound and mammography detects additional cancers in Japanese women

Adding ultrasound to standard mammography tests in breast screening could result in improved rates of detection for breast cancer in women in Japan, according to a new study, published in The Lancet.

6 Nov 2015

Only one in three women in Germany well-informed about mammography screening

Only one in three women participating in Germany's mammography screening programme (MSP) is well-informed about it: the higher the level of education, the greater the chance of women making an informed decision.

4 Nov 2015

Study describes successful intervention to decrease breast cancer screening anxiety

Recent American Cancer Society breast cancer screening guidelines consider the anxiety created by false-positive mammography an "important but not critical outcome" when deciding who should be screened. In other words, in these guidelines, the chance that mammography will create needless cancer worry is a light thumb on the scale against breast cancer screening in some populations.

23 Oct 2015

Women who visit higher volume mammography facilities more likely to benefit from screening

Women who visit mammography facilities with higher total interpretive volumes are more likely to benefit from screening, according to a new study published in the Journal of Medical Screening.

16 Oct 2015

Gamma Medica secures CE Mark approval to distribute LumaGEM Molecular Breast Imaging system within EEA

Gamma Medica, Inc., a breast imaging medical device company, today announced the CE Mark approval allowing for the sale and distribution of the LumaGEM® Molecular Breast Imaging (MBI) system within the European Economic Area (EEA). Gamma Medica is finalizing distribution partners in strategic markets across the EEA.

12 Oct 2015

GE unveils different breast cancer tests for different breasts

With an estimated 494,000 new cases per year, breast cancer is by far the most common cancer amongst women across Europe. Particularly affected are women with dense breast tissue because of the difficultly it can cause when trying to detect cancer early using mammography.

5 Oct 2015

Seno completes PIONEER Pivotal Study of non-invasive Imagio breast imaging system

Seno Medical Instruments, Inc., the company pioneering the development of opto-acoustic technology as a new tool to improve the process of diagnosing breast cancer, announced today it has completed the final phase of the company's U.S.-based PIONEER Pivotal Study of the Imagio® breast imaging system.

1 Oct 2015

Researchers roll out updated online breast cancer risk calculator

Growing up, Charlotte Gard knew she came from a long line of women who developed breast cancer. The New Mexico State University assistant professor always expected her mother to develop it, like her grandmother before her, so she knew she wanted to contribute to research that would help fight the disease that kills more than 40,000 women in the U.S. every year.

30 Sep 2015

New review article discusses benefits, limitations of current screening mammography practices

While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate.